This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Myeloproliferative diseases
MYELOPROF
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1053 |
4. Check minimum number of eventsNone |
1053 |
5. Include endpoints |
4014 |
6. Filter based on genotype QC (FinnGen only) |
3359 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Myeloproliferative diseases
based on the number of shared cases.
Similar with more cases:
- Liquid cancers
- Liquid cancers, including Hilmo
- Malignant neoplasm
- Malignant neoplasm, including Hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3359 | 1772 | 1587 |
| Unadjusted period prevalence (%) | 0.68 | 0.63 | 0.73 |
| Median age at first event (years) | 63.93 | 62.41 | 65.64 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3452
- Matched controls
- 34520
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
TPH00, ,
SPAT
150.5
317.2
158
11
D45
ICD-10 Finland
Polycythaemia vera
1625.4
307.7
1311
13
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
307.7
343
*
L01XX05
ATC
hydroxycarbamide; oral
5399.1
307.7
1950
7
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
+∞
307.7
467
*
XW000
NOMESCO Finland
Bone marrow biopsy
26.7
307.7
1212
685
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
+∞
307.7
1446
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
5727.0
307.7
503
*
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
+∞
307.7
546
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
38.9
307.7
412
120
B99
ICPC
Blood/lymph/spleen disease other
63.1
307.7
191
32
D75.2
ICD-10 Finland
Essential thrombocytosis
4985.2
307.7
1087
*
SPAT1074
SPAT
Venesection
156.9
307.7
314
22
L03AB05
ATC
interferon alfa-2b; parenteral
110.6
307.7
237
23
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
66.4
307.7
281
46
TPH00
NOMESCO Finland
Phlebotomy
297.7
307.7
464
18
189
Kela drug reimbursment
Imatinib
152.0
307.7
187
13
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
109.7
307.7
2319
632
L01XX35
ATC
anagrelide; oral
+∞
282.2
267
*
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
1317.0
254.2
245
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.9
243.4
914
2931
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
35.7
213.2
134
39
M04AA01
ATC
allopurinol; systemic
3.5
204.0
918
3277
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
881.2
172.5
168
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
23.5
163.2
118
52
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
+∞
160.7
153
*
174
Kela drug reimbursment
Ruxolitinib
+∞
160.7
153
*
D75.1
ICD-10 Finland
Secondary polycythaemia
17.6
159.7
131
77
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
15.0
152.4
136
94
212
Kela drug reimbursment
Gout
7.4
152.1
227
324
B74
ICPC
Malignant neoplasm blood other
47.5
150.5
88
19
L01XE01
ATC
[U] imatinib
181.4
149.9
156
9
374
Kela drug reimbursment
Ruxolitinib
+∞
148.0
141
*
L01EJ01
ATC
ruxolitinib; oral
+∞
132.1
126
*
L03AB04
ATC
interferon alfa-2a; parenteral
159.6
131.3
138
9
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
15.0
125.8
112
77
L01EA01
ATC
imatinib; oral
263.8
124.9
127
5
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
27.7
123.8
84
31
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.2
121.5
546
1899
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
13.2
119.9
115
90
D75.0
ICD-10 Finland
Familial erythrocytosis
61.0
107.6
60
10
B28
ICPC
Limited function/disability (B)
20.2
105.5
81
41
316
Kela drug reimbursment
Imatinib
260.2
99.2
101
*
WW500
NOMESCO Finland
Blood transfusion
4.0
88.4
264
697
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
50.7
86.5
50
10
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
22.5
84.6
62
28
L03AA04, ,
ATC
28.4
83.2
56
20
B03XA02
ATC
darbepoetin alfa; parenteral
5.0
77.8
172
358
L01XE18
ATC
[U] ruxolitinib
+∞
77.4
74
*
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
6.7
72.3
116
178
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
11.7
67.2
69
60
152
Kela drug reimbursment
Nilotinib
+∞
64.8
62
*
B04
ICPC
Blood symptom/complaint
10.0
62.3
71
72
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
14.0
59.6
55
40
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
55.1
1884
14049
B03XA01
ATC
erythropoietin; parenteral
7.3
53.4
79
111
XX7BT
NOMESCO Finland
Radioactive phosphorus therapy
+∞
51.2
49
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
17.0
50.5
42
25
127
Kela drug reimbursment
Transplant complication
5.7
50.2
95
172
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
18.8
49.2
39
21
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
10.0
49.0
56
57
L01XX28
ATC
[U] imatinib
474.2
47.4
47
*
150
Kela drug reimbursment
Dasatinib
+∞
47.0
45
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
5.8
46.6
86
152
B01AB05
ATC
enoxaparin; parenteral
1.7
43.1
1198
8271
328
Kela drug reimbursment
Nilotinib
+∞
42.8
41
*
L01XE06
ATC
[U] dasatinib
+∞
40.7
39
*
L01XE08
ATC
[U] nilotinib
+∞
40.7
39
*
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
12.7
40.1
39
31
L01EA03
ATC
nilotinib; oral
+∞
39.7
38
*
R50.9
ICD-10 Finland
Fever, unspecified
1.9
39.1
577
3300
A05AA02
ATC
ursodeoxycholic acid; oral
4.8
37.4
84
177
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.4
36.5
266
1160
L01AB01
ATC
busulfan; systemic
+∞
34.4
33
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
3.9
33.4
101
268
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
32.5
1083
7702
C03CA01
ATC
furosemide; systemic
1.6
31.0
1233
9108
306
Kela drug reimbursment
Erythropoietin and darbepoetin
9.3
30.9
37
40
B01AC14
ATC
[U] anagrelide
+∞
30.2
29
*
2384A
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Polycythaemia vera
+∞
29.2
28
*
L01EA02
ATC
dasatinib; oral
+∞
29.2
28
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
29.2
450
2594
9875/3-C42.1
ICD-O-3
Chronic myelogenous leukemia, BCR/ABL positive of bone marrow
+∞
28.2
27
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
42.9
27.7
34
8
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
27.5
459
2708
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.0
27.0
300
1547
I81
ICD-10 Finland
Portal vein thrombosis
7.1
26.7
40
57
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.2
26.6
242
1158
324
Kela drug reimbursment
Dasatinib
+∞
26.1
25
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
25.8
786
5425
S97
ICPC
Chronic ulcer skin
2.0
25.0
275
1413
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.4
24.9
175
750
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
24.7
363
2056
D47.0
ICD-10 Finland
Histiocytic and mast cell tumours of uncertain and unknown behaviour
47.0
23.3
28
6
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
22.5
865
6255
R04.0
ICD-10 Finland
Epistaxis
1.9
21.9
307
1711
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
8.5
21.9
28
33
B75
ICPC
Neoplasm blood benign/unspecified
115.8
21.6
23
*
D73.5
ICD-10 Finland
Infarction of spleen
20.8
21.2
31
15
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
5.2
20.8
42
81
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
25.6
20.4
28
11
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
19.9
352
2104
170
Kela drug reimbursment
Bosutinib
+∞
19.8
19
*
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
105.7
19.6
21
*
XW000, ,
SPAT
40.3
19.5
24
6
WW200
NOMESCO Finland
Immunization
2.7
19.1
100
372
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
55.3
18.9
22
*
PH_2
NOMESCO Finland
Other procedures on veins
+∞
18.8
18
*
20899
ICD-8 Finland
Polycythaemia vera
+∞
18.8
18
*
C90.0
ICD-10 Finland
Multiple myeloma
3.6
18.4
61
173
SPAT1088
SPAT
Blood transfusion
5.3
18.2
36
68
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.6
18.2
43
95
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
2.4
18.0
121
509
B73
ICPC
Leukaemia
16.6
17.8
28
17
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
7.6
17.8
25
33
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.9
17.8
246
1365
L03AA02
ATC
filgrastim; parenteral
2.4
17.6
116
484
B01AA03
ATC
warfarin; systemic
1.5
17.4
708
5143
L04AD01
ATC
ciclosporin; systemic
3.2
17.3
69
221
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.0
17.1
195
1015
2387X
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[STATUS LYMPHO- ET MYELOPROLIFERATIVUS NUD]
+∞
16.7
16
*
Z3231
NOMESCO Finland
Registered nurse
1.4
16.3
871
6648
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.0
16.1
191
1006
C95.9
ICD-10 Finland
Leukaemia, unspecified
47.7
16.0
19
*
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
16.0
554
3890
K99
ICPC
Cardiovascular disease other
2.4
15.9
113
488
R71
ICD-10 Finland
Abnormality of red blood cells
6.9
15.7
24
35
L01EA04
ATC
bosutinib; oral
+∞
15.6
15
*
360
Kela drug reimbursment
Bosutinib
+∞
15.6
15
*
D75
ICD-10 Finland
Other diseases of blood and blood-forming organs
160.7
15.5
16
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.9
15.3
186
988
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.9
15.3
73
259
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
15.1
432
2908
D64.9
ICD-10 Finland
Anaemia, unspecified
1.6
14.9
408
2721
J01MA12
ATC
levofloxacin; systemic
1.4
14.4
613
4478
H02AB06
ATC
prednisolone; systemic
1.3
14.3
1537
13017
D69.1
ICD-10 Finland
Qualitative platelet defects
17.0
14.3
22
13
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
27.3
14.3
19
7
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.3
14.2
104
455
D47.7
ICD-10 Finland
Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
22.3
14.2
20
9
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
42.7
14.1
17
*
D68.8
ICD-10 Finland
Other specified coagulation defects
3.7
13.9
43
117
J02AC03
ATC
voriconazole; systemic
10.5
13.7
26
25
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
13.6
13.7
23
17
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
2.6
13.6
76
293
J01DB01
ATC
cefalexin; oral
1.4
13.6
2654
24408
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
16.2
13.4
21
13
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
13.3
901
7111
T14.5
ICD-10 Finland
Injury of blood vessel(s) of unspecified body region
4.1
13.2
35
85
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
13.2
340
2234
WZC00
NOMESCO Finland
Treatment plan or consultation
1.3
13.0
1133
9279
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
3.8
12.9
38
100
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
12.8
574
4226
2387B
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[THROMBOCYTHAEMIA IDIOPATHICA]
+∞
12.5
12
*
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
3.0
12.5
54
182
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.2
12.4
105
490
L57.0
ICD-10 Finland
Actinic keratosis
1.5
12.2
396
2733
PD4AD
NOMESCO Finland
CT of lower extremity arteries
3.5
12.2
41
118
V03AC03
ATC
deferasirox; oral
37.7
12.2
15
*
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
12.1
821
6465
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.5
12.0
370
2530
C07AB07
ATC
bisoprolol; oral
1.3
11.9
1694
14768
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
11.9
704
5426
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
2.7
11.9
61
226
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
2.2
11.9
95
433
ZX120
NOMESCO Finland
Intravenous
1.6
11.8
297
1939
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.4
11.7
628
4763
XQ848
NOMESCO Finland
Dermatological photography
2.1
11.6
105
503
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
11.6
572
4275
K29
ICPC
Cardiovascular sympt/complt other
1.8
11.5
160
890
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
11.5
510
3740
NHQ40
NOMESCO Finland
Amputation of toe
2.7
11.5
61
230
Z2221
NOMESCO Finland
Medical doctor
1.3
11.5
797
6292
C94.5
ICD-10 Finland
Acute myelofibrosis
+∞
11.5
11
*
M10.9
ICD-10 Finland
Gout, unspecified
1.6
11.5
251
1585
L04AA01
ATC
[U] ciclosporin
3.0
11.4
50
170
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
20.1
11.1
16
8
A02BC02
ATC
pantoprazole; systemic
1.3
11.1
2246
20386
C03DA01
ATC
spironolactone; oral
1.5
11.1
427
3049
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.3
11.0
83
370
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
43.4
10.9
13
*
D47
ICD-10 Finland
Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
43.4
10.9
13
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
10.9
1292
10965
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.7
10.9
188
1116
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
3.7
10.8
33
89
D73.1
ICD-10 Finland
Hypersplenism
15.5
10.8
17
11
ZYC01
NOMESCO Finland
Remote contact by phone
1.7
10.8
179
1051
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.9
10.7
131
699
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.3
10.7
80
355
A46
ICD-10 Finland
Erysipelas
1.4
10.6
489
3609
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
1.9
10.6
127
674
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
8.5
10.5
22
26
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
2.0
10.4
113
579
L01XE14
ATC
[U] bosutinib
+∞
10.4
10
*
2051A
ICD-9 Finland
Myeloid leukaemia, Chronic
+∞
10.4
10
*
2387A
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[MYELOFIBROSIS]
+∞
10.4
10
*
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
32.6
10.3
13
*
ZY010
NOMESCO Finland
Hospital outpatient
1.9
10.2
127
683
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
10.2
366
2579
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
10.2
418
5659
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.5
10.1
277
1845
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
10.1
387
2762
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.3
9.9
659
5156
B01AB04
ATC
dalteparin; parenteral
1.7
9.8
161
942
B02BX05
ATC
eltrombopag; oral
11.4
9.5
17
15
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
9.1
9.5
19
21
WX892
NOMESCO Finland
Monitored bed care
1.6
9.5
240
1569
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
2.6
9.5
54
212
B86
ICPC
OTHER HAEMATOLOGICAL ABNORMALITY
30.1
9.4
12
*
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
4.4
9.3
23
53
UJF32
NOMESCO Finland
Coloscopy
1.3
9.3
839
6845
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.0
9.3
40
135
N02AX02
ATC
tramadol; systemic, rectal
1.3
9.3
1355
11728
B01AB10
ATC
tinzaparin; parenteral
1.5
9.2
341
2417
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.3
9.1
66
290
C92.7
ICD-10 Finland
Other myeloid leukaemia
36.8
9.0
11
*
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
7.0
9.0
21
30
AA1AD
NOMESCO Finland
CT of head and brain
1.3
9.0
973
8120
JN3AD
NOMESCO Finland
Abdominal CT examination
1.4
8.9
416
3071
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
3.1
8.9
35
112
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.0
8.9
91
458
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.5
8.9
266
1806
B01AC04
ATC
clopidogrel; oral
1.3
8.8
560
4349
TGC00
NOMESCO Finland
Bronchial lavation
2.1
8.8
84
413
J01FF01
ATC
clindamycin; systemic
1.3
8.7
796
6502
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
1.8
8.7
134
772
TQW99
NOMESCO Finland
Other minor procedure on skin
1.7
8.5
168
1034
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
90.3
8.4
9
*
R06.0
ICD-10 Finland
Dyspnoea
1.3
8.4
877
7275
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
2.3
8.4
60
262
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.5
8.4
284
1977
ZX112
NOMESCO Finland
Subcutaneous
2.2
8.4
71
333
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
8.3
8
*
373
Kela drug reimbursment
Ponatinib
+∞
8.3
8
*
WA010
NOMESCO Finland
Adjuvant whole body radiotherapy
+∞
8.3
8
*
H02AB09
ATC
hydrocortisone; systemic
2.1
8.3
72
341
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.5
8.3
290
2033
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
8.3
612
4853
I82.0
ICD-10 Finland
Budd-Chiari syndrome
14.5
8.2
13
9
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.5
8.2
225
1500
R51.80
ICD-10 Finland
Headache
1.4
8.2
409
3056
M79.6
ICD-10 Finland
Pain in limb
1.2
8.1
1317
11480
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.2
8.1
65
298
D58.2
ICD-10 Finland
Other haemoglobinopathies
17.2
8.1
12
7
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
2.4
8.0
55
236
NGQ20
NOMESCO Finland
Amputation of lower leg
3.5
8.0
26
74
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.6
8.0
200
1307
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
1.8
7.8
113
638
ZXE00
NOMESCO Finland
One hour or less
1.2
7.8
1118
9605
A07AA02
ATC
nystatin; oral
1.6
7.7
180
1158
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.5
7.7
209
1391
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
7.7
420
3183
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.3
7.6
57
254
ZXD05
NOMESCO Finland
Urgent procedure
1.3
7.6
859
7183
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.5
7.6
259
1808
L17
ICPC
Foot/toe symptom/complaint
1.3
7.5
922
7782
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
1.8
7.5
107
603
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.2
7.4
1108
9549
J01CA04
ATC
amoxicillin; systemic
1.2
7.4
2500
23418
175
Kela drug reimbursment
Deferasirox
+∞
7.3
7
*
L01EJ04, ,
ATC
+∞
7.3
7
*
1529, ,
Kela drug reimbursment
+∞
7.3
7
*
I50.0
ICD-10 Finland
Congestive heart failure
1.5
7.3
261
1838
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
6.8
7.3
17
25
S91.0
ICD-10 Finland
Open wound of ankle
2.7
7.3
36
132
J01MA14
ATC
moxifloxacin; systemic
1.4
7.1
262
1853
B59
ICPC
Blood and Immunity, Other therap proced/minor surg NEC
30.1
7.1
9
*
J05AB11
ATC
valaciclovir; oral
1.3
7.0
408
3119
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.4
7.0
297
2160
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
7.5
6.9
15
20
I73.8
ICD-10 Finland
Other specified peripheral vascular diseases
8.3
6.8
14
17
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
2.6
6.8
36
137
N02BE01
ATC
paracetamol; systemic, rectal
1.3
6.8
2920
27936
3039, ,
Kela drug reimbursment
9.3
6.8
13
14
1517, ,
Kela drug reimbursment
9.3
6.8
13
14
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.6
6.6
138
864
3AC01, ,
NOMESCO Finland
2.7
6.6
33
122
-69
ICPC
Other reason for encounter NEC
1.7
6.5
111
659
A04AA01
ATC
ondansetron; systemic, rectal
1.4
6.5
240
1700
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.4
6.5
311
2308
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
5.3
6.4
18
34
S18
ICPC
Laceration/cut
1.2
6.4
1478
13247
D06BB10
ATC
imiquimod; topical
1.6
6.4
155
1005
K49
ICPC
Cardiovascular, Other preventive procedure
70.0
6.4
7
*
J05AX18
ATC
letermovir; oral
70.0
6.4
7
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.2
6.4
998
8614
A41.9
ICD-10 Finland
Sepsis, unspecified
1.7
6.4
111
663
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.6
6.4
137
864
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.8
6.4
94
536
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.6
6.4
136
857
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.2
6.4
1019
8821
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
1.7
6.3
110
657
TPH07
NOMESCO Finland
Cathetrisation of artery
1.4
6.3
344
2604
D69.5
ICD-10 Finland
Secondary thrombocytopenia
5.5
6.3
17
31
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.4
6.3
254
1830
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
3.0
6.3
27
92
28999
ICD-8 Finland
Other disease of blood and blood-forming organs, Other and unspecified
+∞
6.3
6
*
N17.8
ICD-10 Finland
Other acute renal failure
2.3
6.0
43
189
L04AX02
ATC
thalidomide; oral
10.0
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
935
551
22.90
307.65
1.5
1.5
—
—
—
0
0
1005
2789
4.67
307.65
11.0
4.0
1.23
0.65
%
9.69
550
849
2886
16252
5.73
307.65
19.7
6.2
0.22
0.19
e9/l
6.01
2693
14029
2866
16054
5.63
307.65
18.4
6.1
1.93
1.90
e9/l
0.24
2697
13975
1102
309
51.92
307.65
1.1
1.1
—
—
—
0
0
1445
3202
7.04
307.65
3.9
2.5
77.84
68.73
e9/l
14.21
1051
2365
2859
15781
5.72
307.65
18.0
6.0
0.08
0.04
e9/l
15.73
2643
13412
2781
14550
5.69
307.65
19.9
6.3
8.44
9.05
%
16.83
2720
13580
2747
14510
5.37
307.65
18.7
6.2
60.69
57.86
%
28.38
2697
13807
1052
555
26.83
307.65
1.3
1.2
27.47
39.15
u/l
0.86
876
486
2379
4006
16.89
307.65
11.4
3.9
282.16
245.82
u/l
13.48
2326
3766
2087
8366
4.78
307.65
5.1
2.8
347.31
350.30
umol/l
0.65
1962
7270
1662
4123
6.85
307.65
4.2
2.5
1.88
1.80
%
2.43
1527
3645
2783
14786
5.55
307.65
19.5
6.3
24.81
26.88
%
19.21
2734
13963
2782
14518
5.72
307.65
19.5
6.2
2.74
2.84
%
1.97
2722
13548
2773
14510
5.63
307.65
19.9
6.3
1.06
0.67
%
100.85
2713
13529
2857
15737
5.73
307.65
18.1
6.0
0.64
0.60
e9/l
2.03
2642
13372
2925
17729
5.26
307.36
24.5
9.3
5.24
4.19
e9/l
19.47
2723
15298
1364
5054
3.81
301.44
3.1
2.7
22.30
22.04
%
0.26
1307
4685
1409
5448
3.68
289.92
3.0
2.6
2.40
2.28
g/l
12.15
1346
5017
1456
5807
3.61
284.54
3.1
2.7
13.14
12.49
umol/l
2.47
1398
5399
1116
3875
3.78
267.08
5.4
3.3
5.67
4.60
e9/l
3.36
964
3291
459
882
5.85
231.72
2.8
2.3
3.32
3.60
g/l
3.99
438
841
2627
17003
3.28
198.01
11.8
6.6
12.28
11.85
umol/l
0.79
2571
16206
338
568
6.49
194.97
9.6
3.3
1.69
1.49
%
0.49
302
502
164
6
287.91
162.09
8.1
1.0
—
—
—
0
0
562
1691
3.78
159.26
1.9
1.7
1.11
1.55
g/l
25.22
489
1460
2193
13823
2.61
155.42
4.4
3.1
152.16
139.48
ug/l
0.64
2070
12762
89
23
39.69
145.83
1.1
1.0
—
—
—
0
0
224
373
6.35
129.54
9.9
3.3
65.46
57.09
%
5.99
186
314
352
882
4.33
127.53
2.5
2.1
93.86
90.85
%
1.65
317
861
126
5
261.55
123.85
13.4
1.0
—
—
—
0
0
2075
13563
2.33
123.23
26.5
12.0
0.05
0.00
e9/l
4.86
1814
11034
1535
8884
2.31
121.35
2.8
2.4
4.59
2.87
mg/l
25.96
1344
7637
333
862
4.17
115.23
1.8
1.6
—
—
—
0
0
2379
16869
2.32
110.87
9.7
7.5
1.21
1.21
mmol/l
0.02
2075
14521
2973
23887
2.76
95.56
18.7
8.4
84.00
80.50
u/l
3.52
2913
22640
894
4550
2.30
90.92
6.2
5.9
1.04
1.03
mmol/l
0.32
852
4219
236
611
4.07
81.09
7.8
5.3
783.16
573.34
iu/ml
0.22
31
87
2097
15150
1.98
79.37
9.1
6.7
1.22
1.21
mmol/l
4.52
1970
13943
278
828
3.56
77.99
3.0
2.4
178.40
197.82
%
2.82
270
785
532
2363
2.48
72.09
2.8
2.9
10.25
10.64
g/l
1.02
496
2170
1504
9960
1.90
71.22
2.1
1.7
19.81
20.27
nmol/l
0.56
1346
8339
990
5701
2.03
70.63
4.8
3.2
0.82
0.82
mmol/l
0.45
951
5354
634
3100
2.28
68.82
2.7
2.7
66.58
66.25
g/l
0.48
585
2829
2025
14901
1.87
67.43
6.9
5.1
35.72
35.19
g/l
4.02
1934
13935
103
153
6.91
66.20
7.6
3.0
1.50
1.09
%
1.21
103
153
277
937
3.13
63.04
3.6
2.8
1.38
1.66
mg/l
8.15
266
837
435
1867
2.52
62.96
1.9
2.0
1.42
1.42
g/l
0.02
405
1700
185
487
3.96
61.94
3.4
2.6
358.45
1845.89
u/ml
1.20
11
37
690
3646
2.12
60.98
5.2
2.6
7.16
8.61
umol/l
1.51
633
3226
882
5177
1.95
57.73
2.8
2.1
31.46
29.77
s
10.37
839
5032
1979
14858
1.78
57.54
2.7
2.2
91.98
95.08
pmol/l
2.34
1263
7775
1241
8163
1.81
56.52
6.0
4.1
83.71
87.42
%
5.40
1188
7991
2365
18963
1.78
52.19
6.5
5.2
6.61
6.80
mmol/l
5.47
2299
18095
1046
6799
1.77
47.88
2.1
1.7
1.18
1.42
mg/l
1.85
835
5335
308
1289
2.53
46.51
3.2
3.6
36.90
65.02
mg/l
1.46
277
1095
308
1290
2.52
46.43
3.2
3.5
48.62
99.04
mg/l
0.61
276
1094
91
177
5.25
44.44
1.6
1.5
—
—
—
0
0
91
177
5.25
44.44
1.6
1.5
—
—
—
0
0
56
65
8.74
44.39
1.6
1.5
—
—
—
0
0
2662
22551
1.79
43.57
5.8
4.5
12.14
13.31
mm/h
3.39
2530
21009
328
1530
2.26
38.62
2.7
2.4
3.49
3.73
g/l
1.50
299
1393
328
1531
2.26
38.55
2.7
2.4
6.80
7.46
g/l
11.57
300
1393
328
1531
2.26
38.55
2.7
2.4
4.18
4.20
g/l
0.20
300
1395
916
6071
1.69
37.42
1.9
1.8
1094.45
1169.04
nmol/l
1.71
710
4567
266
1153
2.42
37.05
3.2
3.3
4.90
3.87
ratio
0.15
168
675
309
1430
2.27
37.03
2.7
2.4
2.92
2.92
g/l
0.04
280
1293
1960
15688
1.58
36.29
20.9
17.1
1.34
1.30
inr
2.73
1675
13157
149
484
3.17
36.12
1.3
1.4
164.21
157.27
au/ml
0.25
38
145
279
1315
2.22
31.88
2.7
2.4
10.82
10.34
g/l
0.81
247
1167
279
1327
2.20
31.16
2.9
2.4
1.39
1.00
g/l
0.87
240
1131
870
6001
1.60
29.15
2.4
1.9
—
—
—
0
0
534
3243
1.76
29.08
6.4
7.2
10.08
10.52
mmol/l
0.73
507
3102
1423
10950
1.51
29.07
3.5
3.3
2088.73
1503.60
ng/l
2.44
1262
9522
240
1113
2.24
28.48
2.9
2.3
0.02
0.02
g/l
0.03
211
995
233
1075
2.25
27.99
2.8
2.3
0.00
0.00
g/l
-0.00
200
939
832
5732
1.59
27.82
1.6
1.5
2.36
2.56
g/l
1.91
556
3407
220
995
2.29
27.71
2.9
2.4
0.00
0.00
g/l
-0.00
200
938
206
908
2.35
27.54
2.4
1.5
—
—
—
0
0
158
620
2.62
27.10
2.4
1.6
—
—
—
0
0
136
494
2.82
27.09
1.2
1.2
302.31
270.70
u/ml
0.51
85
289
91
267
3.47
26.02
2.5
2.4
19.30
37.65
iu/ml
1.06
12
37
198
880
2.33
25.97
2.3
1.5
—
—
—
0
0
93
283
3.35
25.13
1.4
1.8
3.13
4.46
mg/l
4.60
88
277
69
172
4.07
24.94
4.0
2.1
210.46
222.91
e6/l
0.18
61
154
426
2545
1.77
24.29
2.0
1.6
—
—
—
0
0
100
325
3.14
24.28
2.9
1.6
—
—
—
0
0
101
350
2.94
21.97
2.9
1.6
—
—
—
0
0
1290
10132
1.44
21.84
4.6
3.2
32.97
37.85
u/l
1.39
1230
9530
43
81
5.36
21.82
1.3
1.2
69.56
86.87
%
2.45
25
45
42
83
5.11
20.23
1.3
1.5
73.76
85.54
%
0.89
25
48
436
2756
1.67
20.05
3.5
4.0
1.22
1.23
mmol/l
2.76
378
2388
61
169
3.66
19.08
4.0
2.0
1181.42
547.78
e6/l
0.51
50
139
31
49
6.37
18.82
1.3
1.3
70.06
76.44
%
0.33
16
16
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
31
49
6.37
18.82
1.3
1.3
68.00
72.93
%
0.20
16
15
47
110
4.32
18.51
1.3
1.4
—
—
—
0
0
269
1516
1.84
18.49
2.1
1.9
1.55
2.31
ug/l
0.74
241
1332
50
125
4.04
18.07
3.9
1.7
—
—
—
0
0
639
4519
1.51
18.00
2.1
1.8
—
—
—
0
0
60
172
3.53
17.86
2.0
2.7
37.36
40.77
%
0.51
28
99
58
163
3.60
17.78
3.5
1.6
—
—
—
0
0
58
163
3.60
17.78
3.5
1.6
—
—
—
0
0
58
163
3.60
17.78
3.5
1.6
—
—
—
0
0
58
163
3.60
17.78
3.5
1.6
—
—
—
0
0
3077
28778
1.64
17.75
31.8
18.0
20.75
25.80
mg/l
18.06
2751
24171
47
114
4.17
17.69
1.3
2.3
86.40
24105.95
u/ml
—
5
20
49
123
4.03
17.62
3.9
1.7
—
—
—
0
0
49
123
4.03
17.62
3.9
1.7
—
—
—
0
0
1297
10481
1.38
17.53
2.7
2.2
137.12
213.71
u/l
5.45
1227
9885
103
411
2.55
17.16
1.2
1.2
2.31
3.61
u/ml
0.69
48
147
446
2956
1.58
16.78
2.1
2.2
408.65
379.87
nmol/l
1.87
415
2717
80
287
2.83
16.42
3.0
1.5
—
—
—
0
0
80
287
2.83
16.42
3.0
1.5
—
—
—
0
0
80
287
2.83
16.42
3.0
1.5
—
—
—
0
0
55
158
3.52
16.34
1.9
2.3
81.60
99.26
%
2.95
50
151
1720
14637
1.35
16.28
5.4
2.8
—
—
estimate
—
0
0
123
549
2.29
16.03
1.3
1.3
—
—
—
0
0
176
905
2.00
15.94
3.8
3.5
2.81
1.87
index
0.30
105
460
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
216
1198
1.86
15.61
3.7
2.9
0.37
0.35
iu/ml
0.17
128
657
23
33
7.01
15.25
1.3
1.8
—
—
—
0
0
97
402
2.45
14.96
1.2
1.2
4.00
5.91
u/ml
0.54
50
184
151
754
2.05
14.85
1.6
1.4
—
—
—
0
0
95
392
2.46
14.79
1.1
1.1
—
—
—
0
0
157
800
2.01
14.61
1.2
1.3
—
—
—
0
0
353
2295
1.60
14.32
4.1
3.8
5.14
5.16
kpa
0.14
326
2193
584
4230
1.46
14.30
2.2
1.9
—
—
—
0
0
160
829
1.98
14.21
1.2
1.2
97.33
103.77
titre
0.09
15
69
2888
26917
1.45
13.97
5.6
4.5
1.33
1.29
mmol/l
1.61
2735
24412
132
645
2.09
13.78
1.5
1.4
—
—
—
0
0
80
316
2.57
13.68
2.8
2.9
—
—
—
0
0
1000
7994
1.35
13.65
5.3
2.5
—
—
—
0
0
348
2282
1.58
13.60
1.8
1.7
—
—
—
0
0
220
1281
1.77
13.56
2.3
2.1
317.68
659.54
ug/l
1.30
211
1218
306
1948
1.63
13.53
3.8
3.6
1.85
1.99
mmol/l
0.24
216
1436
81
324
2.54
13.50
1.3
1.2
—
—
—
0
0
1245
10296
1.33
13.46
3.1
2.7
54.24
68.57
u/l
1.16
1160
9510
473
3325
1.49
13.43
2.2
2.2
0.21
0.21
g/l
0.02
436
3090
1301
10838
1.32
13.32
3.9
3.5
113.48
85.48
e6/l
0.17
1024
8350
25
24
10.48
13.21
1.4
1.6
—
—
—
0
0
2564
23489
1.36
13.20
44.5
22.1
15.51
13.75
%
195.97
2551
23154
58
199
2.95
12.97
1.8
1.9
—
—
—
0
0
89
381
2.37
12.83
1.1
1.2
110.02
115.24
%
0.84
84
349
152
806
1.93
12.64
1.8
2.0
15.57
12.33
mg/l
1.23
135
741
161
877
1.88
12.35
1.5
1.6
0.23
0.24
g/l
0.83
150
835
164
902
1.86
12.21
1.4
1.6
1.12
1.19
g/l
2.46
155
858
943
7585
1.33
12.07
3.0
2.8
4.43
5.37
e6/l
2.36
876
6935
1879
16583
1.29
12.06
4.3
4.2
0.01
0.10
estimate
0.55
486
3352
47
149
3.18
12.05
1.6
2.5
1429.66
1095.40
u/ml
0.33
47
149
128
652
2.00
11.97
1.6
1.4
—
—
—
0
0
1847
16277
1.29
11.93
4.3
4.2
0.00
0.00
estimate
0.80
500
3501
1421
12109
1.29
11.91
4.6
4.1
101.72
110.11
e6/l
0.17
1061
8674
69
272
2.57
11.89
1.7
1.5
—
—
—
0
0
1867
16486
1.29
11.82
4.3
4.2
5.00
3.97
estimate
0.11
515
3603
1131
9365
1.31
11.71
3.9
3.4
0.45
0.46
e6/l
0.02
867
6956
1364
11579
1.29
11.71
3.7
3.5
2.34
2.36
mmol/l
5.63
1247
10452
28
64
4.40
11.43
1.5
1.3
—
—
—
0
0
77
328
2.38
11.27
1.2
1.2
52.03
64.77
u/l
1.27
72
289
109
537
2.06
11.19
1.6
1.4
—
—
—
0
0
271
1770
1.58
10.75
2.9
3.4
4.39
4.43
pmol/l
0.27
228
1559
1472
12726
1.27
10.59
4.6
4.2
45.15
98.61
ng/l
0.90
1174
9575
204
1252
1.67
10.42
2.0
1.9
—
—
—
0
0
218
1361
1.64
10.42
2.8
2.0
—
—
—
0
0
203
1247
1.67
10.34
2.7
2.7
—
—
—
0
0
2097
18951
1.27
10.31
4.0
3.4
59.61
53.07
u/l
2.39
2000
17595
365
2585
1.46
9.87
3.4
2.8
57.19
62.80
ml/min/173m2
2.82
221
1145
1023
8510
1.29
9.86
3.9
3.7
0.01
0.13
estimate
0.70
447
2723
326
2266
1.48
9.70
8.3
8.1
24.67
24.98
mmol/l
0.66
326
2255
92
452
2.06
9.57
1.5
1.5
—
—
—
0
0
91
446
2.07
9.53
1.5
1.5
—
—
—
0
0
41
141
2.93
9.22
1.1
1.2
1.11
1.07
ratio
1.57
34
115
183
1138
1.64
8.92
1.4
1.3
—
—
—
0
0
2931
27837
1.35
8.90
31.4
17.8
75.57
76.69
ml/min/173m2
2.25
2793
25995
95
487
1.98
8.82
6.7
6.5
11.62
12.39
mg/l
0.89
89
455
146
858
1.73
8.79
2.9
2.9
7.72
7.96
kpa
1.13
141
839
539
4188
1.34
8.39
8.1
7.6
11.78
12.11
kpa
0.60
520
4027
539
4188
1.34
8.39
8.1
7.6
4.97
5.11
kpa
2.72
522
4026
838
6915
1.28
8.38
3.3
3.1
2.44
2.46
mmol/l
4.55
766
6205
19
41
4.65
8.34
1.1
1.5
10.00
225719.83
nmol/l
0.49
14
35
452
3426
1.37
8.26
3.9
3.7
—
—
—
0
0
3102
29798
1.40
8.19
34.2
21.8
139.46
139.65
mmol/l
3.89
3062
29228
2438
22692
1.25
8.10
4.8
4.4
15.17
14.95
pmol/l
4.00
2262
20619
3104
29839
1.40
7.98
36.3
22.0
4.01
3.99
mmol/l
5.98
3060
29223
475
3661
1.34
7.78
3.7
3.5
5.73
5.83
kpa
1.21
462
3567
1601
14291
1.22
7.76
2.8
2.5
78.21
78.85
nmol/l
0.40
1450
12739
202
1333
1.55
7.71
1.7
1.8
39.50
39.01
u/l
0.12
173
1160
1077
9246
1.24
7.52
4.3
4.3
0.00
0.00
estimate
1.54
460
3186
23
63
3.67
7.45
1.8
1.4
—
—
—
0
0
480
3735
1.33
7.35
8.5
7.8
94.91
95.45
%
0.85
466
3607
365
2724
1.38
7.33
3.6
3.9
86.19
92.88
ng/l
0.83
322
2322
29
94
3.10
7.27
1.0
1.2
—
—
—
0
0
2214
20498
1.22
7.22
5.5
5.1
2265.48
1935.22
e6/l
0.06
29
311
525
4157
1.31
7.10
8.2
7.5
0.93
0.99
mmol/l
0.10
427
3425
457
3551
1.33
7.06
3.7
3.6
1.43
1.90
mmol/l
1.62
392
3095
181
1194
1.54
6.94
4.5
4.0
24.47
24.90
mmol/l
1.10
163
1093
128
777
1.67
6.92
1.7
1.5
—
—
—
0
0
119
712
1.70
6.80
4.4
4.9
2.70
2.72
mmol/l
0.02
80
497
119
713
1.69
6.76
4.4
4.9
5.02
5.07
kpa
0.25
119
703
2826
26929
1.27
6.76
6.2
5.5
2.05
1.97
mu/l
2.50
2679
24651
10
6
16.71
6.74
1.0
1.0
—
—
—
0
0
50
223
2.26
6.74
1.1
1.2
125.00
116.32
titre
—
6
38
795
6676
1.25
6.65
4.2
4.1
530.01
551.53
ng/l
0.02
647
5509
36
140
2.59
6.53
1.2
1.2
—
—
—
0
0
172
1140
1.54
6.48
1.2
1.2
0.21
1.11
u/ml
—
8
90
27
91
2.98
6.37
1.1
1.0
—
—
—
0
0
2930
28094
1.28
6.33
6.5
5.3
1.32
1.46
mmol/l
62.79
2796
25784
11
10
11.03
6.29
1.7
1.1
—
—
—
0
0
105
621
1.71
6.28
1.3
1.2
106.67
394.91
titre
—
6
55
77
415
1.87
6.28
1.2
1.4
279.95
316.23
pmol/l
0.57
61
355
35
138
2.55
6.19
1.4
5.6
73.07
62.92
mg/l
0.29
30
95
2946
28286
1.28
6.16
6.5
5.4
4.14
4.55
mmol/l
90.51
2827
26147
401
3119
1.32
6.14
2.4
2.5
33.29
55.40
u/l
0.80
344
2626
40
169
2.38
6.12
1.2
1.2
—
—
—
0
0
415
3257
1.31
5.96
7.6
7.3
1.41
1.35
mmol/l
0.39
406
3199
44
197
2.25
5.92
1.5
1.5
8.26
6.81
u/l
0.14
39
162
92
534
1.74
5.91
1.3
1.5
32.47
31.78
g/l
0.24
84
482
1361
12176
1.19
5.89
4.3
4.2
0.01
0.26
estimate
0.80
450
2865
181
1244
1.48
5.77
1.6
1.7
5.83
7.52
iu/ml
0.51
37
286
51
250
2.06
5.49
1.1
1.1
—
—
—
0
0
644
5405
1.24
5.30
3.7
3.2
1.67
2.45
e6/l
2.04
310
2681
287
2173
1.35
5.29
9.5
9.4
24.15
24.28
mmol/l
0.25
280
2133
433
3476
1.28
5.23
9.2
8.4
117.71
121.03
g/l
2.22
426
3395
224
1635
1.40
5.19
4.6
5.0
1.82
1.57
%
1.68
215
1549
130
858
1.54
5.07
1.2
1.2
1.72
3.30
u/ml
—
8
77
80
469
1.72
5.02
1.3
1.4
1862.71
3583.37
e6/l
0.43
56
323
33
141
2.35
4.98
1.4
6.2
—
56.87
—
0
30
129
858
1.52
4.87
1.2
1.3
3.17
8.21
u/ml
1.48
13
140
72
414
1.75
4.84
1.3
1.4
101035.47
89205.49
e6/l
0.08
43
225
3106
30188
1.29
4.73
27.7
12.9
25.16
25.80
u/l
1.33
3057
29241
2978
28809
1.25
4.66
7.3
6.2
2.34
2.62
mmol/l
68.93
2857
26524
382
3064
1.28
4.65
3.0
2.9
4.49
4.47
kpa
0.06
372
2980
137
933
1.49
4.63
1.5
1.5
0.57
8.87
iu/ml
0.62
20
173
74
436
1.71
4.59
2.5
1.4
—
—
—
0
0
35
161
2.19
4.49
2.0
1.3
—
—
—
0
0
35
161
2.19
4.49
2.0
1.3
—
—
—
0
0
2866
27638
1.22
4.48
7.4
7.0
38.17
39.92
mmol/mol
25.72
2737
25645
10
15
6.68
4.46
2.9
4.9
—
—
—
0
0
73
433
1.70
4.43
2.5
1.4
—
—
—
0
0
99
635
1.58
4.42
1.2
1.2
24.00
47.19
u/ml
—
5
74
110
723
1.54
4.41
1.2
1.2
1.31
6.82
u/ml
—
8
47
1725
15988
1.16
4.36
2.8
2.7
—
—
—
0
0
29
127
2.29
4.19
1.2
1.4
—
1687199.83
—
0
6
89
567
1.58
4.11
1.7
2.0
5.02
4.76
mmol/24h
0.31
83
487
124
851
1.47
4.08
2.1
2.2
129.29
127.46
g/l
0.25
97
667
358
2897
1.26
4.07
3.6
3.1
209.20
218.44
ng/l
0.17
334
2656
44
230
1.92
4.05
1.8
1.3
—
—
—
0
0
2903
28093
1.21
4.02
6.1
5.6
5.99
6.03
mmol/l
1.00
2700
25548
14
43
3.26
3.90
1.4
1.0
—
—
—
0
0
115
786
1.48
3.88
1.1
1.2
—
7.94
—
0
7
135
952
1.44
3.87
1.7
1.7
—
—
—
0
0
28
126
2.23
3.83
2.0
1.3
—
—
—
0
0
678
5895
1.19
3.79
3.5
3.1
1.00
1.15
e6/l
0.54
350
3174
44
236
1.88
3.78
1.1
1.1
—
—
—
0
0
135
958
1.43
3.75
1.9
1.8
—
—
—
0
0
70
431
1.64
3.75
2.5
1.3
—
—
—
0
0
71
439
1.63
3.74
1.1
1.1
—
9.58
—
0
19
955
8549
1.16
3.72
3.3
3.2
0.00
0.05
2.15
20
254
626
5417
1.19
3.69
1.3
1.3
28.67
35.14
iu/ml
0.71
185
1662
10
20
5.01
3.68
1.0
1.5
—
—
—
0
0
118
1669
0.70
3.68
1.6
1.8
3.32
3.47
mmol/l
0.81
80
1196
59
350
1.70
3.64
1.1
1.1
1.40
3.41
—
6
52
175
2317
0.74
3.63
2.0
2.1
3.71
3.47
ratio
1.60
136
1854
67
413
1.63
3.59
2.6
1.4
—
—
—
0
0
107
734
1.47
3.57
1.4
1.3
—
—
—
0
0
24
105
2.29
3.52
1.2
1.3
34.76
388.93
ug/l
0.67
15
47
42
228
1.85
3.50
1.8
1.3
—
—
—
0
0
228
1781
1.30
3.46
1.6
1.5
—
—
—
0
0
100
682
1.48
3.45
1.2
1.1
5.41
4.32
—
8
73
1356
12510
1.14
3.37
2.0
1.9
1.44
1.35
mmol/l
2.46
1174
10396
67
421
1.60
3.35
1.4
1.3
0.20
0.23
nmol/l
0.32
48
338
54
324
1.68
3.24
1.4
1.7
—
1374.55
—
0
11
106
743
1.44
3.20
2.3
2.8
35.78
35.94
umol/l
0.02
94
662
256
2052
1.27
3.19
10.1
10.0
15.44
15.93
%
1.74
250
1980
89
604
1.49
3.17
1.6
1.3
12.57
9.98
u/l
1.06
78
485
75
491
1.54
3.16
1.3
1.3
0.18
0.36
nmol/l
—
5
29
427
3622
1.20
3.14
2.4
2.3
168.02
151.45
ug/g
0.30
336
2880
62
389
1.60
3.14
1.3
1.4
272.29
276.13
mosm/kgh2o
0.67
49
293
13
40
3.26
3.13
1.5
1.0
—
—
—
0
0
65
414
1.58
3.10
2.7
1.4
—
—
—
0
0
65
416
1.57
3.04
2.7
1.4
—
—
—
0
0
30
153
1.97
3.04
1.6
1.6
42.89
39.74
g/l
2.96
30
153
40
225
1.79
3.02
1.2
1.1
—
—
—
0
0
3118
30534
1.22
2.97
42.6
23.9
82.81
80.41
umol/l
3.21
3092
30152
736
6562
1.15
2.96
1.3
1.3
1.78
1.41
u/ml
0.28
145
1696
192
1500
1.30
2.95
5.0
5.2
0.89
0.87
%
0.32
182
1417
42
243
1.74
2.90
1.1
1.1
—
—
—
0
0
229
1840
1.26
2.83
4.0
3.9
47.13
47.06
%
0.01
221
1810
40
231
1.74
2.79
1.2
1.1
—
—
—
0
0
40
231
1.74
2.79
1.2
1.1
—
—
—
0
0
575
5067
1.16
2.70
1.3
1.3
8.39
12.77
u/ml
1.09
200
1888
268
2209
1.23
2.65
8.2
6.7
24.04
24.53
mmol/l
1.24
259
2114
103
747
1.39
2.63
1.4
1.6
—
—
—
0
0
40
236
1.70
2.61
1.4
1.5
—
—
—
0
0
136
1033
1.33
2.60
1.5
1.4
270.45
272.53
ug/g
0.04
84
619
45
275
1.64
2.58
1.2
1.1
—
—
—
0
0
63
418
1.52
2.56
1.6
1.4
—
—
—
0
0
120
898
1.35
2.54
1.4
1.3
26.85
29.93
iu/l
0.57
105
764
56
363
1.55
2.53
4.8
3.7
—
—
—
0
0
10
31
3.23
2.51
1.0
1.0
—
—
—
0
0
36
210
1.72
2.46
1.4
1.5
—
—
—
0
0
32
183
1.76
2.35
1.4
1.4
1.28
1.19
nmol/l
0.20
21
134
37
221
1.68
2.34
1.2
1.1
—
—
—
0
0
779
7077
1.13
2.34
1.7
1.8
17570283.68
26356889.87
pmol/l
0.20
609
5824
46
292
1.58
2.30
1.5
1.5
—
—
—
0
0
225
1855
1.23
2.26
1.4
1.3
60.50
54.32
au/ml
0.17
14
126
24
127
1.90
2.25
1.9
2.1
498.00
795.75
e6/l
0.78
16
89
22
113
1.95
2.25
2.0
1.9
5711.86
21305.43
e6/l
0.40
14
58
93
684
1.37
2.23
1.6
1.3
—
—
—
0
0
93
684
1.37
2.23
1.6
1.3
—
—
—
0
0
212
1741
1.23
2.22
3.5
3.5
1.02
1.02
ratio
0.28
198
1578
36
218
1.66
2.18
1.5
1.5
—
—
—
0
0
9
30
3.00
2.14
2.4
4.7
—
—
—
0
0
201
1649
1.23
2.13
3.1
3.2
24.63
25.32
mmol/l
1.96
191
1593
35
212
1.66
2.13
1.8
2.0
7.99
8.39
mmol/l
0.29
35
212
24
130
1.85
2.12
2.6
3.0
33.98
22.88
mu/l
0.54
24
124
243
2035
1.21
2.11
2.6
2.4
21.64
22.10
au/ml
0.02
25
169
270
2284
1.20
2.11
2.6
3.0
125.64
128.15
g/l
0.89
256
2218
5
10
5.01
2.07
1.0
1.0
—
—
—
0
0
218
1812
1.22
2.05
1.4
1.3
158.02
228.48
u/ml
1.12
203
1678
109
837
1.31
2.00
1.2
1.2
—
—
—
0
0
42
272
1.55
1.97
1.0
1.1
—
—
—
0
0
197
1628
1.22
1.97
2.1
2.2
0.00
0.53
estimate
0.51
45
478
2254
23283
0.91
1.97
47.7
23.3
326.54
331.75
g/l
55.62
2241
23145
7
21
3.34
1.96
1.6
1.0
—
—
—
0
0
109
843
1.30
1.91
1.2
1.2
—
—
—
0
0
24
135
1.78
1.91
1.9
2.5
67.00
104.49
umol/l
0.72
13
77
55
381
1.45
1.89
7.0
5.9
7.51
7.51
mmol/l
0.00
47
325
12
52
2.31
1.87
1.2
1.3
—
—
—
0
0
15
72
2.09
1.86
2.5
1.1
—
—
—
0
0
33
205
1.62
1.85
2.0
1.7
602.93
329.91
mu/l
0.50
27
162
126
998
1.27
1.85
2.0
1.3
—
—
—
0
0
23
129
1.79
1.85
2.2
1.8
47.19
47.12
ug/l
0.00
23
124
51
729
0.70
1.84
1.2
1.2
1.46
1.53
g/l
1.23
51
729
48
326
1.48
1.83
4.8
3.5
14.51
11.77
index
1.33
39
174
5
12
4.17
1.82
1.6
1.1
247.20
284.50
nmol/l
—
5
12
8
29
2.76
1.79
2.4
2.7
0.50
0.79
u/field
—
8
29
446
3983
1.14
1.77
1.5
1.4
—
—
—
0
0
46
664
0.69
1.76
1.2
1.1
0.64
0.65
ratio
0.11
11
90
26
155
1.68
1.72
1.1
1.1
14.06
17.86
u/ml
—
5
63
14
68
2.06
1.70
1.9
1.6
—
—
—
0
0
21
119
1.77
1.66
2.0
2.6
0.61
0.62
mmol/l
0.01
21
119
8
31
2.58
1.66
1.5
1.2
—
—
—
0
0
10
42
2.38
1.61
1.1
1.1
—
—
—
0
0
89
689
1.30
1.60
1.4
1.4
26.83
34.09
e6/l
0.15
64
505
16
84
1.91
1.59
1.2
1.7
—
—
—
0
0
28
175
1.60
1.57
2.7
3.8
—
—
—
0
0
14
71
1.98
1.53
2.4
2.5
5.36
450.44
ug/l
0.57
14
71
37
250
1.49
1.50
6.1
5.3
50.29
39.94
u/ml
0.15
12
74
158
1320
1.21
1.49
2.2
3.3
360.73
3980.56
u/ml
1.02
134
1134
9
37
2.44
1.47
1.6
1.5
—
—
—
0
0
89
698
1.28
1.47
1.5
1.4
779.01
1212.75
e6/l
0.25
70
543
318
2820
1.14
1.44
2.7
2.5
0.39
0.45
e6/l
0.27
305
2707
5
16
3.13
1.44
1.6
1.8
—
—
—
0
0
7
29
2.42
1.39
1.0
1.1
91.43
94.90
titre
—
7
29
33
222
1.49
1.38
1.3
1.2
—
—
—
0
0
16
89
1.80
1.37
1.4
1.2
36.33
16.75
%
—
6
12
9
42
2.15
1.33
1.6
1.6
—
—
—
0
0
31
453
0.68
1.33
1.3
1.6
1039.99
952.82
mu/l
0.15
22
366
13
68
1.92
1.33
1.0
1.2
—
—
—
0
0
137
1145
1.20
1.31
1.7
1.6
0.37
0.34
mg/l
0.26
67
527
26
168
1.55
1.31
7.9
6.7
12.49
131.78
ug/l
0.57
17
101
14
76
1.85
1.29
1.0
1.2
—
—
—
0
0
19
305
0.62
1.27
1.4
1.5
—
—
—
0
0
433
3946
1.11
1.26
5.5
5.2
31.57
33.13
%
2.51
332
2520
3128
30916
1.13
1.25
55.1
27.3
382.04
245.55
e9/l
314.06
3084
30255
77
608
1.27
1.25
1.2
1.3
194.54
218.56
miu/ml
0.18
26
248
3128
30919
1.12
1.24
54.8
27.2
94.11
91.50
fl
37.43
3104
30546
3128
30921
1.12
1.23
55.7
27.8
40.05
39.96
%
0.40
3104
30533
3128
30921
1.12
1.23
55.0
27.2
4.38
4.44
e12/l
3.62
3074
30149
8
37
2.16
1.21
5.6
5.9
57.63
63.03
ug/min
—
8
32
3128
30925
1.12
1.21
55.1
27.3
8.84
6.81
e9/l
35.66
3074
30153
30
205
1.47
1.19
1.1
1.1
36.02
41.48
mg/l
0.51
25
168
3128
30928
1.12
1.19
55.4
27.5
130.74
133.86
g/l
19.40
3106
30568
336
3031
1.12
1.19
2.3
2.4
5.31
7.23
ug/l
2.20
271
2664
130
1095
1.19
1.17
1.5
1.6
30.11
19.71
u/ml
0.36
16
218
20
125
1.60
1.17
1.3
1.3
123.12
167.17
mmol/24h
2.15
20
125
32
223
1.44
1.16
4.0
1.7
—
—
—
0
0
86
696
1.24
1.15
1.2
1.1
15.76
5.58
eliau/ml
—
9
66
23
150
1.54
1.14
1.3
1.7
—
—
—
0
0
27
184
1.47
1.10
1.1
1.1
—
—
—
0
0
26
176
1.48
1.10
1.0
1.1
1.84
11.45
iu/ml
—
5
52
89
729
1.23
1.09
6.8
6.9
105.20
105.08
mmol/l
0.08
79
653
335
3040
1.11
1.08
1.6
1.8
1.52
1.52
%
0.04
285
2615
11
193
0.57
1.07
1.5
1.7
—
—
—
0
0
17
266
0.64
1.06
1.4
1.5
67.69
58.64
ug/l
—
10
214
28
195
1.44
1.04
1.5
1.2
—
—
—
0
0
5
22
2.27
1.03
1.4
1.0
—
—
—
0
0
5
22
2.27
1.03
1.6
1.9
26.20
26.14
mg/l
—
5
22
5
22
2.27
1.03
1.2
1.0
7.76
6.22
u/ml
—
5
22
18
114
1.58
1.02
1.7
1.5
17.29
22.61
%
0.49
18
106
27
188
1.44
1.01
1.3
1.8
—
—
—
0
0
405
3739
1.09
0.95
3.0
4.1
11.77
20.36
ug/l
0.64
314
3072
16
246
0.65
0.94
1.4
1.4
—
—
—
0
0
30
217
1.39
0.93
1.8
1.3
2.56
1.67
u/ml
0.16
20
127
113
966
1.18
0.92
5.9
3.9
3.96
3.90
mmol/l
0.82
113
957
26
184
1.42
0.91
2.1
2.4
—
—
—
0
0
25
176
1.42
0.90
1.2
1.1
—
—
—
0
0
27
193
1.40
0.90
1.5
1.2
—
—
—
0
0
21
143
1.47
0.89
1.1
1.8
3.09
5.44
ug/l
0.55
13
111
140
1221
1.15
0.89
1.3
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
161
1.43
0.86
1.2
1.1
—
—
—
0
0
54
432
1.25
0.86
1.1
1.1
13.10
22.08
au/ml
—
7
86
8
44
1.82
0.85
1.4
1.2
—
—
—
0
0
34
256
1.33
0.84
2.4
2.2
689.40
633.62
ml
0.35
20
167
197
1766
1.12
0.84
1.2
1.2
93.99
135.76
u/ml
1.12
64
640
19
272
0.70
0.81
1.0
1.0
935.71
711.90
ng/l
0.82
14
178
15
97
1.55
0.81
1.1
1.2
6.80
11.61
pmol/l
—
5
38
266
2430
1.10
0.81
1.5
1.4
—
—
—
0
0
8
47
1.70
0.80
1.4
1.2
—
—
—
0
0
92
784
1.18
0.80
1.8
2.3
61.65
61.09
%
0.08
92
779
19
271
0.70
0.80
1.0
1.0
31.21
42.75
ng/l
1.25
14
178
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
19
270
0.70
0.78
1.0
1.0
244.21
312.07
ng/l
1.47
14
181
11
66
1.67
0.78
1.1
1.1
—
—
—
0
0
105
907
1.16
0.78
1.3
1.4
—
—
—
0
0
21
148
1.42
0.77
1.2
1.2
0.49
0.52
ratio
—
8
84
40
314
1.28
0.76
1.2
1.5
—
—
—
0
0
608
6396
0.94
0.71
3.0
3.4
0.75
0.80
ug/l
0.42
412
4378
15
218
0.69
0.71
1.3
1.6
—
—
—
0
0
56
463
1.21
0.70
1.2
1.1
—
—
—
0
0
7
41
1.71
0.70
2.1
2.3
12.40
17.85
umol/l
—
7
41
14
205
0.68
0.69
1.0
1.5
109.79
83.89
umol/l
0.66
14
205
9
58
1.55
0.69
1.0
1.3
—
—
—
0
0
93
807
1.16
0.68
2.2
1.9
41.27
42.53
nmol/l
0.22
88
775
18
248
0.72
0.65
1.4
1.5
0.80
1.21
ratio
—
9
147
18
248
0.72
0.65
1.4
1.5
1.50
1.17
ratio
—
8
147
18
248
0.72
0.65
1.4
1.5
1.01
0.94
ratio
—
8
147
5
29
1.73
0.64
7.6
6.6
13.00
8.66
%
—
5
29
98
859
1.14
0.63
3.7
3.4
0.77
0.81
nmol/l
0.41
76
701
13
87
1.50
0.63
1.3
1.1
—
—
—
0
0
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
16
113
1.42
0.61
1.4
1.4
2.65
3.12
mmol/l
0.47
16
102
56
473
1.19
0.59
1.7
2.0
32305.24
3347.15
u/l
0.95
13
191
835
8651
0.95
0.57
4.1
4.8
22.32
21.98
%
0.26
416
4442
6
37
1.62
0.55
1.3
1.0
—
—
—
0
0
40
330
1.21
0.54
1.2
1.1
2.67
2.07
eliau/ml
0.30
13
125
8
124
0.64
0.54
1.6
1.3
—
—
—
0
0
6
38
1.58
0.54
1.0
1.2
2.65
1.84
umol/24h
—
6
38
17
125
1.36
0.53
1.0
1.1
1502.35
1626.14
miu/ml
0.17
17
125
27
214
1.26
0.52
1.9
1.8
5.76
9.60
umol/l
0.64
19
144
12
83
1.45
0.51
1.2
1.1
—
—
—
0
0
9
64
1.41
0.51
1.1
1.1
—
—
—
0
0
13
92
1.41
0.50
1.0
1.3
2.64
4.15
umol/l
—
8
78
11
156
0.70
0.49
1.1
1.5
56.49
53.98
ug/l
0.13
11
156
14
101
1.39
0.49
3.9
2.7
4.98
4.83
kpa
0.25
14
101
14
101
1.39
0.49
3.9
2.7
11.79
10.14
kpa
0.98
14
101
15
110
1.37
0.48
1.0
1.2
—
—
—
0
0
13
93
1.40
0.48
1.3
1.1
—
—
—
0
0
13
93
1.40
0.48
1.8
1.6
74.15
450.32
nmol/24h
0.66
13
93
28
226
1.24
0.48
1.6
1.8
114.30
116.87
ng/l
0.05
28
226
12
85
1.41
0.46
1.2
1.1
—
—
—
0
0
26
210
1.24
0.45
1.4
1.3
9.61
9.62
mmol/l
0.01
26
198
129
1400
0.92
0.41
1.0
1.1
—
—
—
0
0
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
44
379
1.16
0.41
1.3
1.6
71.16
60.43
%
0.98
23
226
26
214
1.22
0.39
1.2
1.1
7.49
10.14
nmol/l
—
5
44
11
80
1.38
0.38
1.1
1.1
—
—
—
0
0
5
36
1.39
0.38
1.2
2.0
—
—
—
0
0
373
3893
0.95
0.38
8.4
7.5
—
—
—
0
0
13
98
1.33
0.37
1.2
1.1
—
—
—
0
0
5
37
1.35
0.37
1.2
1.1
—
—
—
0
0
71
786
0.90
0.36
1.6
1.4
—
—
—
0
0
74
669
1.11
0.35
4.1
3.7
28.48
28.90
mg/l
0.03
48
471
34
291
1.17
0.35
1.2
1.3
—
—
—
0
0
12
91
1.32
0.33
1.1
1.1
—
—
—
0
0
14
109
1.29
0.33
1.1
1.1
—
—
—
0
0
90
826
1.09
0.33
1.3
1.3
—
—
—
0
0
20
164
1.22
0.32
1.8
1.4
158.24
222.54
pmol/l
0.45
20
164
79
863
0.91
0.32
1.5
1.6
13308.79
14872.61
e6/l
0.18
58
591
33
285
1.16
0.32
1.2
1.5
19.94
28.74
%
0.84
16
169
81
882
0.92
0.31
2.1
1.9
—
—
—
0
0
18
147
1.23
0.30
1.1
1.1
—
—
—
0
0
32
277
1.16
0.30
1.2
1.3
27.73
28.32
u/l
0.03
24
228
74
808
0.91
0.30
1.9
1.8
—
30.85
—
0
5
30
261
1.15
0.27
1.1
1.2
108.60
103.03
pmol/l
0.28
30
261
705
7211
0.97
0.27
4.4
4.4
1.02
1.22
kg/l
0.50
495
4882
20
168
1.19
0.27
2.2
2.1
16.67
176.66
ug/min
—
6
41
10
128
0.78
0.26
11.4
14.3
810.40
799.74
nmol/l
—
10
123
10
77
1.30
0.26
1.2
1.1
—
—
—
0
0
5
74
0.68
0.26
1.0
1.3
1.25
1.18
mmol/l
—
5
74
43
475
0.90
0.24
1.1
1.1
63.57
91.96
iu/ml
—
7
94
20
171
1.17
0.23
1.3
1.3
15.98
23.29
umol/l
0.82
20
156
17
144
1.18
0.22
1.1
1.1
—
—
—
0
0
13
107
1.22
0.21
1.2
2.2
37.80
94.92
ug/l
0.35
13
95
8
105
0.76
0.21
1.1
1.2
18.37
10.20
mm/h
—
8
105
0
13
0.00
0.21
0.0
1.2
—
7.81
—
0
13
0
14
0.00
0.20
0.0
1.2
—
2.71
—
0
14
6
48
1.25
0.20
1.0
1.0
31.78
39.98
iu/ml
—
6
48
1092
10782
1.02
0.19
5.1
5.8
2.82
3.39
ug/l
0.39
973
9694
40
437
0.91
0.19
1.3
1.5
—
—
—
0
0
11
90
1.22
0.19
1.5
1.2
89.64
107.45
%
0.67
11
78
28
312
0.90
0.19
1.3
1.4
551895.86
74432.55
e6/l
0.85
21
206
10
81
1.24
0.18
1.0
1.4
10.79
9.08
ug/l
—
10
81
33
362
0.91
0.17
1.1
1.1
0.96
3.68
u/ml
3.50
19
182
1150
11374
1.02
0.17
4.1
4.2
13.23
8.84
mg/mmol
1.60
711
7088
8
72
1.11
0.16
6.0
8.1
8.56
5.47
kpa
—
8
72
18
159
1.13
0.15
1.1
1.1
0.90
1.20
u/l
—
7
81
40
430
0.93
0.14
3.0
5.3
343.87
347.83
umol/l
0.06
30
378
1104
11149
0.99
0.14
3.5
3.5
72.73
47.51
mg/l
2.11
707
7149
382
3747
1.02
0.14
1.5
1.4
—
—
—
0
0
14
160
0.87
0.14
1.1
1.1
—
—
—
0
0
31
285
1.09
0.14
1.8
2.0
2.33
1.55
u/field
0.44
21
148
69
726
0.95
0.14
2.0
1.8
—
—
—
0
0
251
2451
1.03
0.13
3.0
2.3
12.78
13.07
nmol/l
0.22
223
2190
20
181
1.11
0.12
1.5
1.2
—
—
—
0
0
46
434
1.06
0.12
2.2
2.2
11.62
21.91
mg/l
3.03
13
151
23
251
0.92
0.12
1.0
1.0
0.04
0.24
u/ml
—
9
91
179
1747
1.03
0.11
1.8
1.9
—
—
—
0
0
76
791
0.96
0.11
1.3
2.0
2.82
11.53
iu/l
0.59
24
302
35
329
1.06
0.10
1.1
1.1
1.67
1.19
u/ml
0.15
20
165
5
44
1.14
0.10
1.4
1.5
59.00
46.09
umol/l
—
5
44
21
193
1.09
0.10
1.6
1.5
—
—
—
0
0
45
428
1.05
0.09
1.1
1.1
0.55
1.65
u/ml
1.70
24
235
5
48
1.04
0.09
1.0
1.8
59.39
47.06
pmol/l
—
5
39
164
1604
1.02
0.09
1.7
1.8
—
—
—
0
0
21
226
0.93
0.08
1.3
1.4
1.12
1.15
promille
0.02
13
177
82
797
1.03
0.07
2.6
3.3
339.06
691.04
u/ml
0.38
71
732
63
647
0.97
0.05
1.3
1.8
0.82
0.86
nmol/l
0.22
55
539
79
776
1.02
0.03
2.7
2.3
237.88
97.34
ug/min
0.70
45
468
18
171
1.05
0.03
1.8
1.2
202.56
137.26
nmol/l
1.74
18
171
11
102
1.08
0.03
1.1
1.1
—
—
—
0
0
10
108
0.93
0.03
1.0
1.0
—
—
—
0
0
1147
11490
1.00
0.02
3.4
3.4
7.15
7.29
mmol/l
0.52
957
9607
31
303
1.02
0.01
1.8
1.5
0.23
0.29
nmol/l
0.63
22
227
64
633
1.01
0.01
1.4
1.5
—
—
—
0
0
35
356
0.98
0.00
1.1
1.1
0.14
1.19
u/ml
2.26
14
149
12
115
1.04
0.00
1.1
1.0
—
—
—
0
0
27
271
1.00
0.00
1.1
1.1
2.98
3.48
u/ml
0.10
12
117
29
293
0.99
0.00
1.1
1.1
1.11
2.12
u/ml
0.81
15
143
25
247
1.01
0.00
1.9
3.0
21.33
31.10
mg/l
0.77
15
183
15
153
0.98
0.00
1.3
1.4
—
—
—
0
0
5
50
1.00
0.00
1.2
1.1
91.22
40.95
u/ml
—
5
50
0
6
0.00
0.00
0.0
1.0
—
1478.67
—
0
6
0
8
0.00
-0.00
0.0
1.8
—
1.28
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
1.58
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.8
—
1.89
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
306.00
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: MYELOPROF – Myeloproliferative diseases
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).